Yahoo Web Search

Search results

  1. Steven M. Paul is an American neuroscientist and pharmaceutical executive. Paul was the former CEO, president, and chairman of Karuna Therapeutics.

  2. SM Paul, RH Purdy. The FASEB Journal 6 (6), 2311-2322. , 1992. 1972. 1992. Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. RB DeMattos, KR Bales, DJ Cummins, JC Dodart, SM Paul, DM Holtzman.

  3. While working at Eli Lilly and Company as Executive Vice President of Science and Technology and President of the Lilly Research Laboratories (LRL), his research team discovered a novel potential new treatment for Alzheimer's disease (an antibody called solanezumab) beleved to clear amyloid plaques from the brain.

  4. People also ask

  5. Paul is a co-founder and board member of Sage Therapeutics (NASDAQ: SAGE) and a co-founder of Voyager Therapeutics (NASDAQ: VYGR) where he served as President, Chief Executive Officer. Dr. Paul is the former director of the Appel Alzheimer’s Disease Research Institute at Weill Cornell Medical College and is currently a Professor of Psychiatry ...

  6. Epub 2010 Feb 19. Authors. Steven M Paul 1 , Daniel S Mytelka , Christopher T Dunwiddie , Charles C Persinger , Bernard H Munos , Stacy R Lindborg , Aaron L Schacht. Affiliation. 1 Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA. smpaulmd@gmail.com. PMID: 20168317. DOI: 10.1038/nrd3078.

    • Steven M. Paul, Daniel S. Mytelka, Christopher T. Dunwiddie, Charles C. Persinger, Bernard H. Munos,...
    • 2010
  7. Jun 28, 2016 · BETHESDA, MD, June 28, 2016 — The Board of Directors of the Foundation for the National Institutes of Health (FNIH) has unanimously elected Board member Steven M. Paul, M.D., as the new Chairman. Dr. Paul’s term began immediately following the May 19, 2016 Board meeting. Dr. Paul succeeds Charles A. Sanders, M.D., who has served as Chairman ...

  8. Dr. Paul is the former director of the Appel Alzheimer’s Disease Research Institute at Weill Cornell Medical College and is currently a Professor of Psychiatry and Neurology at Washington University at St. Louis School of Medicine and a Venture Partner at Third Rock Ventures.

  1. People also search for